EAACI Congress 2025
BackTPS64 - Dermatology 04
Sunday 15 Jun, 12:45 PM -
13:45 PM Glasgow, United Kingdom
Poster Zone
Thematic Poster Session
D3.292
"Evaluating Inflammatory Markers in Chronic Spontaneous Urticaria: Impact of Omalizumab Treatment"
D3.293
Acrodermatitis chronica atrophicans in the field of scleroderma
D3.299
Cholinergic urticaria treated with dupilumab
D3.303
Contact Dermatitis and Rhinoconjunctivitis due to Palisander Wood Exposure in a Cabinetmaker
D3.302
Elevated Kocuria rhizophila contributing to repair of skin barrier function in patients with atopic dermatitis
D3.291
Hereditary angioedema with normal C1Inh and PLG mutation treated with tranexamic acid : Beware of the risk of thrombosis
D3.290
Manifestations of allergic skin lesions in the early childhood and adult population: Epidemiological manifestations of diseases
D3.295
Mental health support for atopic dermatitis patients in the Republic of Kazakhstan
D3.304
Monitoring skin inflammation in atopic dermatitis by non-invasive sampling through skin tape stripping for multiplex protein analysis is complementary to serum biomarkers
D3.298
Monomorphic maculo-papular late age onset cutaneous mastocytosis
D3.294
Serum Lactate Dehydrogenase levels distinguish atopic dermatitis patients with a predominant production of IL-13, IL-5 and IL-9 in response to house dust mite allergen and increased prevalence of allergic comorbidities
D3.296
Urticaria activity, quality of life and disease control in chronic spontaneous urticaria patients in Kazakhstan
